Combination of the toll like receptor agonist and α-Galactosylceramide as an efficient adjuvant for cancer vaccine

BACKGROUND: DNA vaccines have emerged as an attractive approach for the generation of cytotoxic T lymphocytes (CTL). In our previous study, we found That Toll like receptor (TLR) ligands are promising candidates for the development of novel adjuvants for DNA vaccine. To improve the efficacy of DNA v...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Biomed Sci
Main Authors: Gableh, Fateme, Saeidi, Mohsen, Hemati, Shaghayegh, Hamdi, Kasra, Soleimanjahi, Hoorieh, Gorji, Ali, Ghaemi, Amir
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2016
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4727273/
https://ncbi.nlm.nih.gov/pubmed/26811064
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12929-016-0238-3
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares